C Tancrède

1.9k total citations
47 papers, 1.5k citations indexed

About

C Tancrède is a scholar working on Molecular Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, C Tancrède has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Medicine, 15 papers in Infectious Diseases and 13 papers in Epidemiology. Recurrent topics in C Tancrède's work include Antibiotic Resistance in Bacteria (17 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Neutropenia and Cancer Infections (10 papers). C Tancrède is often cited by papers focused on Antibiotic Resistance in Bacteria (17 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Neutropenia and Cancer Infections (10 papers). C Tancrède collaborates with scholars based in France and United States. C Tancrède's co-authors include Antoine Andremont, Sophie Pecquet, P. Raibaud, Catherine Hill, D Baume, Roger Labia, Andreas Karabinis, A. Andremont, B. Leclercq and Michel Barthélémy and has published in prestigious journals such as Applied and Environmental Microbiology, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

C Tancrède

43 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Tancrède France 21 472 419 409 390 213 47 1.5k
Mark LaRocco United States 23 606 1.3× 386 0.9× 253 0.6× 770 2.0× 134 0.6× 61 1.9k
Jeffrey D. Klinger United States 26 258 0.5× 351 0.8× 655 1.6× 466 1.2× 64 0.3× 57 2.2k
P. Y. Chau Hong Kong 20 276 0.6× 343 0.8× 142 0.3× 462 1.2× 98 0.5× 68 1.3k
W. Edmund Farrar United States 23 280 0.6× 481 1.1× 302 0.7× 349 0.9× 45 0.2× 78 1.5k
Agnès Girard United States 19 347 0.7× 359 0.9× 308 0.8× 558 1.4× 85 0.4× 39 1.5k
D. Daneau Belgium 20 309 0.7× 442 1.1× 148 0.4× 505 1.3× 368 1.7× 53 1.6k
L. B. Guze United States 22 453 1.0× 136 0.3× 221 0.5× 772 2.0× 143 0.7× 77 1.7k
J. H. Darrell United Kingdom 17 221 0.5× 274 0.7× 152 0.4× 338 0.9× 246 1.2× 45 1.1k
R. E. Warren United Kingdom 14 420 0.9× 621 1.5× 176 0.4× 419 1.1× 55 0.3× 20 1.3k
R E Warren United Kingdom 19 349 0.7× 276 0.7× 89 0.2× 287 0.7× 115 0.5× 42 1.1k

Countries citing papers authored by C Tancrède

Since Specialization
Citations

This map shows the geographic impact of C Tancrède's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Tancrède with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Tancrède more than expected).

Fields of papers citing papers by C Tancrède

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Tancrède. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Tancrède. The network helps show where C Tancrède may publish in the future.

Co-authorship network of co-authors of C Tancrède

This figure shows the co-authorship network connecting the top 25 collaborators of C Tancrède. A scholar is included among the top collaborators of C Tancrède based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Tancrède. C Tancrède is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ulusakarya, Ayhan, Élisabeth Chachaty, Ali A. Youssef, et al.. (2000). Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies. The Hematology Journal. 1(2). 111–116. 46 indexed citations
3.
Carsenti-Etesse, H., F Doyon, Nicole Desplaces, et al.. (1999). Epidemiology of Bacterial Infection During Management of Open Leg Fractures. European Journal of Clinical Microbiology & Infectious Diseases. 18(5). 315–323. 99 indexed citations
4.
Gautier, Erwan, Jean Bourhis, Anne Fajac, et al.. (1997). Should cytomegalovirus be tested for in both blood and bronchoalveolar lavage fluid of patients at a high risk of CMV pneumonia after bone marrow transplantation?. British Journal of Haematology. 98(1). 222–227. 10 indexed citations
5.
Gautier, Erwan, Élisabeth Carniel, J Génin, & C Tancrède. (1996). Tumor-Like Pyomyositis of the Thigh Caused by Yersinia enterocolitica. Clinical Infectious Diseases. 23(3). 658–659. 2 indexed citations
6.
Chiche, D., Marguerite Guiguet, Antoine Andremont, et al.. (1993). Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial.. PubMed. 2(5). 275–80. 21 indexed citations
7.
Barthélémy, Michel, Jean Péduzzi, Hervé Bernard, C Tancrède, & Roger Labia. (1992). Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum β-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1122(1). 15–22. 121 indexed citations
8.
Tancrède, C. (1992). Role of human microflora in health and disease. European Journal of Clinical Microbiology & Infectious Diseases. 11(11). 1012–1015. 105 indexed citations
9.
Pecquet, Sophie, et al.. (1991). Kinetics of Saccharomyces cerevisiae elimination from the intestines of human volunteers and effect of this yeast on resistance to microbial colonization in gnotobiotic mice. Applied and Environmental Microbiology. 57(10). 3049–3051. 26 indexed citations
10.
Chastagner, P., Oliver Hartmann, C Tancrède, et al.. (1989). Role of parenteral antibiotherapy in gastrointestinal tract flora suppression. A study in children treated with high-dose chemotherapy and autologous bone marrow transplantation.. PubMed. 4(4). 393–8. 5 indexed citations
11.
12.
Leonard, Finola C., et al.. (1989). Use of  -Lactamase-Producing Anaerobes to Prevent Ceftriaxone from Degrading Intestinal Resistance to Colonization. The Journal of Infectious Diseases. 160(2). 274–280. 41 indexed citations
13.
Pico, J L, D. Chiche, F. Fitoussi, et al.. (1988). [Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].. PubMed. 17(37). 1968–70. 8 indexed citations
14.
Pecquet, Sophie, Antoine Andremont, & C Tancrède. (1986). Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora. Antimicrobial Agents and Chemotherapy. 29(6). 1047–1052. 62 indexed citations
15.
Tancrède, C, et al.. (1984). Epidemiology of enterobacteria resistant to cefotaxime in hospital. Journal of Antimicrobial Chemotherapy. 14(suppl B). 53–57. 5 indexed citations
16.
Duval‐Iflah, Yvonne, P. Raibaud, C Tancrède, & M. Rousseau. (1980). R-plasmic transfer from Serratia liquefaciens to Escherichia coli in vitro and in vivo in the digestive tract of gnotobiotic mice associated with human fecal flora. Infection and Immunity. 28(3). 981–990. 60 indexed citations
17.
Guibert, J, et al.. (1980). Première étude pharmacocinétique et thérapeutique sur une nouvelle céphalosporine : le Cefotaxime. Médecine et Maladies Infectieuses. 10(3). 156–162. 1 indexed citations
18.
Tancrède, C, et al.. (1979). [First steps in the bacterial colonization of the digestive tract of neonates (author's transl)].. PubMed. 130 A(1). 69–84. 1 indexed citations
19.
Tancrède, C. (1973). Dosage de gentamycine en cas d'association avec une B. Lactamine. Médecine et Maladies Infectieuses. 3(7). 297–298. 1 indexed citations
20.
Tancrède, C, et al.. (1969). [Developement of serum and urine concentrations of rifampicin during treatment].. PubMed. 17(3). 155–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark LaRocco Breakdown of academic impact, for papers by Jeffrey D. Klinger Breakdown of academic impact, for papers by P. Y. Chau Breakdown of academic impact, for papers by W. Edmund Farrar Breakdown of academic impact, for papers by Agnès Girard Breakdown of academic impact, for papers by D. Daneau Breakdown of academic impact, for papers by L. B. Guze Breakdown of academic impact, for papers by J. H. Darrell Breakdown of academic impact, for papers by R. E. Warren Breakdown of academic impact, for papers by R E Warren
Rankless by CCL
2026